Passenger lymphocyte syndrome following organ and stem cell transplantation: current insights and clinical implications - Scorecard - MDSpire

Passenger lymphocyte syndrome following organ and stem cell transplantation: current insights and clinical implications

  • By

  • Zhong-yu Kang

  • Xue-ya Han

  • Chun Liu

  • Wei Liu

  • Dai-hong Li

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Understanding Passenger Lymphocyte Syndrome in the Context of Organ and Stem Cell Transplants: Insights and Clinical Relevance

At a Glance

CategoryDetail
Condition
Key MechanismsAlloimmune complication characterized by donor-derived B lymphocytes producing antibodies against recipient red blood cell antigens, as stated in the source.
Target Population
Care Setting

Key Highlights

  • Remove unsupported phrases and ensure all statements are directly sourced.

Guideline-Based Recommendations

Diagnosis

  • Use serological assays for antibody screening and identification to support diagnosis, as mentioned in the source.

Management

  • Supportive transfusion with donor-type red blood cells, plasma exchange, or B-cell-targeted therapy such as rituximab, as stated in the source.

Monitoring & Follow-up

    Risks

      Patient & Prescribing Data

      Recipients of ABO-mismatched solid organ or hematopoietic stem cell transplants.

      Management strategies are heterogeneous; many cases resolve spontaneously.

      Clinical Best Practices

      • Ensure all practices are directly referenced from the source material.

      Related Resources & Content

      Original Source(s)

      Related Content